The NIH Catalyst, January-February 2002

T H E N I H C A T A L Y S T	J A N U A R Y – F E B R U A R Y 2002

NEW FAES COURSE:

DEMYSTIFYING CLINICAL MEDICINE FOR PH.D. SCIENTISTS

Win Arias

"Demystifying Medicine for Ph.D. Students, Fellows, and Staff," a new course offered at the FAES Graduate School (Medi 552), is based on a successful similar venture developed and conducted by Win Arias at Tufts School of Medicine in Medford, Mass., for the past 15 years. The course will begin on January 29th and continue twice weekly (Tuesday and Thursday 4:00–5:30 p.m.) until mid-May. Enrollment is limited to 170 students (who must have a Ph.D. or be in a Ph.D. program). Registration is required.

The goal is to "demystify medicine" for basic scientists through clinical presentations of patients, their pathology, and the diagnostic and therapeutic advances relevant to their cases that are linked to advances in basic biology. The course will be conducted by clinical and basic scientists and directed by Arias, who is currently an NIH Fogarty Scholar (see "A Win-Win Situation," The NIH Catalyst, September–October 2001).

The curriculum includes approximately 20 major diseases and related basic biologic advances. A tentative schedule appears below and at the web site.

The course is designed to bridge the ever-increasing gap between advances in basic biology and their application to human disease. Typically, Ph.D. scientists do not receive training in pathobiology and have little understanding of clinical disease, advances in diagnosis and therapy, and the major unsolved clinical problems that challenge basic research.

Not only is learning its own excuse for being, but there is also a practical aspect to taking this course. Because of the decline in physician-scientists, more tenure-track positions in clinical departments in many of the nation’s best medical schools are available for Ph.D. scientists with the clinical background offered in a course like this.

In such academic settings, Ph.D. scientists work with rather than for physician-scientists. One third of the graduates of the one-semester course in Pathobiology at Tufts have tenure-track positions in outstanding clinical departments (and most others have traditional academic and industrial positions).

For more information, contact Arias.

Jan. 29 Jan.31	T Th	Masur Bldg. 50	Steve Holland John Robbins	Global Infections Vaccines To Prevent Them
Feb. 4 Feb. 7	T Th	Masur Bldg. 50	Cliff Lane John Coffin	AIDS: The Disease HIV: The Virus
Feb. 11 Feb. 14	T Th	Masur Bldg. 50	Tiren Finkel Brian Brewer	Atherosclerosis: The #1 Disease Cholesterol Biology: The Good and the Bad
Feb. 19 Feb. 21	T Th	Masur Bldg. 50	Bob Balaban Bob Adelstein	Cardiac Diagnosis in the 21st Century Myosins: Essential Components
Feb. 26 Feb. 28	T Th	Masur Bldg. 50	Joel Moss Joel Moss	The Major Lung Diseases Genetics of Lung Disease
Mar. 5 Mar. 7	T Th	Masur Bldg. 50	Bill Gahl Juan Bonifacino	Lysosomal Diseases and Novel Therapies Lysosomal Biology
Mar. 12 Mar. 14	T Th	Masur Bldg. 50	Phil Gordon/Mark Reitman Ron McKay/SnorriThorgeirsson	Diabetes and Obesity Stem Cells
Mar. 19 Mar. 21	T Th	Masur Bldg. 50	David Harlan Polly Matzinger	Transplantation Immune Recognition of Allografts
Mar. 26 Mar. 28	T Th	Bldg. 50 Bldg. 50	Warren Strober John Robbins	Inflammatory Bowel Disease The Infectious Etiology of Autoimmunity
Apr. 2 Apr. 4	T Th	Bldg. 50 Bldg. 50	Harvey Alter Joe Grisham	Hepatitis Viruses and Liver Disease Liver Regeneration
Apr. 9 Apr. 11	T Th	Bldg. 50 Bldg. 50	Jay Hoofnagle/Win Arias Curt Harris/Snorri Thorgeirsson	Hepatocellular Cancer: The Disease Hepatocellular Cancer: Mechanisms
Apr. 16 Apr. 18	T Th	Masur Bldg. 50	Marston Linehan Tom Waldmann	Inherited and Acquired Renal Cancer Lymphoid Growth Factors: Treatment
Apr. 23 Apr. 25	T Th	Masur Bldg. 50	Alan Wayne Carole Thiele	Leukemias Cell Cycle: Biology and Therapeutic Targets
Apr. 30 May 2	T Th	Bldg. 50 Bldg. 50	Lyuba Varticovski Ira Pastan	Lymphoma Causes and Cures Immunotoxins: A Novel Therapeutic Strategy
May 7 May 9	T Th	Bldg. 50 Bldg. 50	Susan Bates Michael Gottesman	Anti-Cancer Drug Resistance: A Major Issue Cellular and Molecular Mechanisms of Drug Resistance
May 14 May 16	T Th	Bldg. 50 Bldg. 50	Steve Rosenberg Lance Liotta	Immunotherapy of Melanoma Molecular and Cellular Basic of Metastasis
May 21 May 23	T Th	Bldg. 50 Bldg. 50	Rick Klausner/Tom Cech	Role of Ph.D.s in Biomedical Rresearch

INTRO TO TECH TRANSFER

An intro to tech transfer course (Genl 313), will be held Tuesdays from 5:30 to 7:30 p.m.. Topics include intellectual property, definitions of a patentable invention and an inventor, collaborative research, the patent application process, and patent litigation, infringement and interference. Special topics include third party considerations in natural products development.

For registration information, see the FAES Spring Catalog. Classes start Jan. 29 and will be held at the Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852.

Note: Late registration for classes at the FAES Graduate School will be accepted at the school’s office (one Cloister Court/Building 60, Suite 230) until March 8 with a $10 late fee.

Return to Table of Contents